Hermès Made A Statement With Its Latest Results, And Ozempic Was Linked To A Lower Risk Of Alzheimer’s
- Author
- Finimize
- Published
- Fri 25 Oct 2024
- Episode Link
- None
Hermès made a splashy statement with its latest results, outshining its luxury rivals, while Novo Nordisk’s popular weight-loss drug has been linked to a lowered risk of Alzheimer’s.
Today’s stories:
